Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 5 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Injections 39 Carboplatin 33 Capecitabine 24 Paclitaxel 23 Cisplatin 23 Docetaxel 22 pembrolizumab 21 Oxaliplatin 21 Gemcitabine 21 Bevacizumab 19 Pemetrexed 18 Fluorouracil 13 Irinotecan 12 Cyclophosphamide 11 osimertinib 9 Nivolumab 9 Dexamethasone 8 Topotecan 7 Leucovorin 7 130-nm albumin-bound paclitaxel 7 venetoclax 6 toripalimab 6 tislelizumab 6 regorafenib 6 lenvatinib 6 fludarabine 6 Doxorubicin 6 Cetuximab 6 daratumumab 5 atezolizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × INDUSTRY × Imlunestrant × Clear all

NCT07287098 2026-05-22

preEMBER

Eli Lilly and Company

Phase 2 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡